3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
Stomach Neoplasms
7
Esophageal Neoplasms
6
Inflammatory Breast Neoplasms
4
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Sarcoma
1
Her2-Positive Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
Paclitaxel
6
Carboplatin
6
Gemcitabine
3
pembrolizumab
2
Irinotecan
2
Erlotinib Hydrochloride
2
Capecitabine
2
Bevacizumab
2
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
etoposide phosphate
1
erythromycin propionate-N-acetylcysteinate
1
entrectinib
1
cobimetinib
1
belinostat
1
atezolizumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
alectinib
1
Vemurafenib
1
Surveys and Questionnaires
1
Oxaliplatin
1
HhAntag691
1
Everolimus
1
Etoposide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Unknown Primary
×
Epirubicin
×
Clear all
No trials found.